Related Experiment Video

Updated: Oct 2, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

Improvements in Parental Sleep, Fear of Hypoglycemia, and Diabetes Distress With Use of an Advanced Hybrid

Erin C Cobry1, Alessandro Bisio2, R Paul Wadwa1

  • 1Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO.

Diabetes Care
|February 24, 2022
PubMed

Insights

Parental sleep quality impacts glycemic control in children with type 1 diabetes. Using the Control-IQ hybrid closed-loop system improved both parent sleep and child glycemic outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Diabetes Technology

Background:

  • Parental sleep quality is a potential factor influencing glycemic control in children with type 1 diabetes.
  • The Tandem Control-IQ (CIQ) hybrid closed-loop (HCL) system is an advanced technology for managing type 1 diabetes in youth.

Purpose of the Study:

  • To analyze the impact of parental sleep quality on glycemic and psycho-behavioral outcomes in children with type 1 diabetes using the CIQ HCL system.
  • To evaluate improvements in sleep and psychosocial measures for parents identified as "poor" sleepers.

Main Methods:

  • A multicenter, randomized trial involving children aged 6-13 years with type 1 diabetes.
  • Assessment of parental sleep quality using the Pittsburgh Sleep Quality Index (PSQI) at baseline.
  • Analysis of glycemic and psycho-behavioral outcomes before and after CIQ system use in children of "poor" sleeping parents (n=49).

Main Results:

  • Significant improvements were observed in nocturnal time in range (P < 0.001) and time hyperglycemic (P < 0.001) for children.
  • Parental and child psycho-behavioral measures, including Hypoglycemia Fear Survey scores and Problem Areas in Diabetes scale, showed significant improvement (P < 0.001).
  • Parental PSQI scores significantly improved (P < 0.001), with 27 parents transitioning from "poor" to "good" sleepers.

Conclusions:

  • The CIQ HCL system use in youth with type 1 diabetes led to significant improvements in sleep and psychosocial measures for parents who were initially poor sleepers.
  • These improvements coincided with enhanced nocturnal glycemic control in their children.
  • The study highlights a significant relationship between HCL system use and improved parental sleep quality, impacting pediatric diabetes management.
Abstract

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

787
Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

141

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
364
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
884
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
293
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.5K